Stock CUV CLINUVEL PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Clinuvel Pharmaceuticals Limited

Equities

CUV

AU000000CUV3

Market Closed - Australian S.E.
Other stock markets
 02:10:23 2024-05-23 am EDT 		5-day change 1st Jan Change
15.4 AUD +2.53% Intraday chart for Clinuvel Pharmaceuticals Limited +2.12% -3.75%
May. 23 Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America MT
Apr. 29 Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% MT

Evolution of the average Target Price on Clinuvel Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

0f626a3.BpoYROKY_tDwnPpOqZsl9JkqcbbFOJPR1FcHh4QPQ_M.X6NqJZaooaSc0q0My6xquNRrI8XxceKEjjZWts59JKNU1jU0q96pgqfTqw~3711407c5dd41db3d14fcc450bb54c35

Analyst Recommendations on Clinuvel Pharmaceuticals Limited

Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.4 AUD
Average target price
25.6 AUD
Spread / Average Target
+66.25%
High Price Target
46.3 AUD
Spread / Highest target
+200.65%
Low Price Target
16 AUD
Spread / Lowest Target
+3.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Clinuvel Pharmaceuticals Limited

Morgans Financial

Ratings for Clinuvel Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CUV Stock
  4. Consensus Clinuvel Pharmaceuticals Limited